Patch testing with serial dilutions of various isothiazolinones in patients hypersensitive to methylchloroisothiazolinone/methylisothiazolinone.

Marléne Isaksson, Birgitta Gruvberger, Magnus Bruze

Research output: Contribution to journalArticlepeer-review

Abstract

In 2005, methylisothiazolinone (MI) on its own came into use as a preservative. Prior to that, MI was always present together with methylchloroisothiazolinone (MCI). Can the pattern of reactivity to the separate active ingredients in allergic patients tell us something about the primary sensitizer?
Original languageEnglish
Pages (from-to)270-275
JournalContact Dermatitis
Volume70
Issue number5
DOIs
Publication statusPublished - 2014

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Pediatrics/Urology/Gynecology/Endocrinology (013240400), Occupational and Environmental Dermatology Unit (013241310)

Subject classification (UKÄ)

  • Dermatology and Venereal Diseases

Fingerprint

Dive into the research topics of 'Patch testing with serial dilutions of various isothiazolinones in patients hypersensitive to methylchloroisothiazolinone/methylisothiazolinone.'. Together they form a unique fingerprint.

Cite this